argenx SE
ARGX
ISIN NL0010832176 / Valor 24766616
argenx SE
UMushroom community rating:
About company
Argenx SE is a biotechnology company that specializes in developing innovative therapies for the treatment of severe autoimmune diseases and cancer. The company leverages its proprietary technology platform to create a portfolio of first-in-class product candidates, which are developed in collaboration with academic partners. Argenx's approach focuses on translating breakthroughs in immunology into effective medicines, aiming to address unmet medical needs. The company's flagship product, efgartigimod, is designed to modulate the immune system and is being explored for multiple autoimmune indications. Argenx is headquartered in the Netherlands and operates globally, with a commitment to advancing its pipeline through rigorous research and development efforts.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
64855 M
Market cap (USD)
68,751
Daily traded volume (Shares)
600 / 594.2
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Laura Sofie Tohver
Viktor Stockel
Claudia Stadelmann
EQUITIES OF THE SAME SECTOR
